Return to Prolotherapy Nutrition Connection Page

Bibliography

[1] Seaman DR. The diet-induced proinflammatory state: A cause of chronic pain and other degenerative diseases? Journal of Manipulative and Physiological Therapeutics. 2002 Apr 30; 25(3): 168–179.


[2] Ross J. Amino acids and diet in chronic pain management. Practical Pain Management Journal. 2012


[3] Advincula de Araújo L, Addor F, Campos PMBGM. Use of silicon for skin and hair care: An approach of chemical forms available and efficacy. Anais Brasileiros de Dermatologia. 2016; 91(3): 331–335.


[4] Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HFJ, Evans BAJ, Thompson RPH, Powell JJ, Hampson GN. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone. 2003; 32(2): 127–135.


[5] Martin KR. The chemistry of silica and its potential health benefits. Journal of Nutrition, Health & Aging. 2007 Mar-Apr; 11(2): 94-97.


[6] Barel A, Calomme M, Timchenko A, De Paepe K, Demeester N, Rogiers V, Clarys P, Berghe DV. Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin. Archives of Dermatological Research. 2005 Oct 1; 297(4): 147–153.


[7] Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HFJ, Evans BAJ, Thompson RPH, Powell JJ, Hampson GN. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone. 2003; 32(2): 127–135; Martin KR. The chemistry of silica and its potential health benefits. Journal of Nutrition, Health & Aging. 2007 Mar-Apr; 11(2): 94–97; Geusens P, Pavelka K, Rovensky J, Vanhoof J, Demeester N, Calomme M, Vanden Berghe D. A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis. BMC Musculoskeletal Disorders. 2017; 18(1): 2.


[8] Jurkić LM, Cepanec I, Pavelić SK, Pavelić K. Biological and therapeutic effects of orthosilicic acid and some orthosilicic acid releasing compounds: New perspectives for therapy. Nutrition & Metabolism. 2013; 10(1): 2.


[9] Ross J. Amino acids and diet in chronic pain management. Practical Pain Management Journal. 2012


[10] https://en.wikipedia.org/wiki/Endorphins [cited 2017 August 25].


[11] uhl JH. Fibromyalgia and the serotonin pathway. Alternative Medicine Review. 1998 Oct; 3: 367–375.


[12] Ehrenpreis S, Balagot RC, Myles S, Advocate C, Comaty JE. Further studies on the analgesic activity of D-Phenylalanine in mice and humans. In Endogenous and Exogenous Opiate Agonists and Antagonists: Procedures of the International Narcotics Research Club Convention (pp. 379–382). Philadelphia, Pennsylvania: Elsevier, 1979.


[13] https://lidtke.com/?s=endorphigen.


[14] Sampson HA. Food allergy. Journal of the American Medical Association. 1997; 278(22): 1888–1894; Van de Laar MA, van de Korst JK. Food intolerance in rheumatoid arthritis: A double blind controlled trial of the clinical effects of elimination of milk allergens and azo dyes. Annuals of Rheumatological Diseases. 1992 Mar 1; 51(3): 298–302.


[15] Cotter N. Diet and Pain. In Integrative Pain Management (p. 255). New York, New York: Oxford University Press, 2016.


[16] Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PHR, Hadjivassiliou M, Kaukinen K, Rostami K, Sanders DS. Schumann M, Ullrich R, Villalta D, Volta U, Catassi C, Fasano A. Spectrum of gluten-related disorders: Consensus on new nomenclature and classification. BMC Medicine. 2012; 10(1): 13.


[17] Lubrano E, Ciacci C, Ames PRJ, Mazzacca G, Ordente P, Scarpa R. The arthritis of coeliac disease: Prevalence and pattern in 200 adult patients. Rheumatology. 1996; 35(12): 1314–1318.


[18] Usai P, Francesa M, Piga M, Cacace E, Lai MA, Beccaris A, Piras E, Nasa GL, Mulargia M, Balestrieri A. Adult celiac disease is frequently associated with sacroiliitis. Digestive Diseases and Sciences. 1995; 40(9): 1906–1908.

[19] Zipser RD, Patel S, Yahya KZ, Baisch DW, Monarch E. Presentations of adult celiac disease in a nationwide patient support group. Digestive Diseases and Sciences. 2003; 48(4): 761–764.


[20] Lynd FT et al. The Naalehu disease (in Hawaii). American Journal of Veterinary Research. 1965; 26: 1344–1349; Krook L, Wasserman RH, McEntee K, Brokken TD, Teigland MB. Cestrum diurnum poisoning in Florida cattle. Cornell Veterinarian. 1975; 65(10): 557–575.


[21] Childers NF, Margoles MS. An apparent relation of nightshades (solanaceae) to arthritis. Journal of Neurological and Orthopedic Medical Surgery. 1993; 12: 227–231.


[22] Childers NF. Arthritis-Childer’s Diet to Stop It: Nightshades, Aging and Ill Health, 4th ed. Florida: Horticultural Publications, 1993.


[23] Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C. Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomized, placebo-controlled clinical trial. The Lancet. 2001; 357 (9252): 251–256.


[24] Runhaar J, Rozendaal R, van Middelkoop M, Bijlsma JW, Doherty M, Dziedzic K, Lohmander LS, McAlindon T, Zhang W, Bierma-Zeinstra SM. No treatment effects of oral glucosamine for subgroups of knee and hip osteoarthritis patients: An individual patient data meta-analysis from the OA trial bank. Osteoarthritis and Cartilage. 2017; 25: S408–S409.


[25] Hochberg MC. Martel-Pelletier J, Monfort J, Möller I, Castillo JR, Arden N, Berenbaum F, Blanco FJ, Conaghan PG, Domenech G, Henrotin Y, Pap T, Richette P, Sawitzke A, du Souich P, Pelletier JP. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: A multicentre, randomized, double-blind, non-inferiority trial versus celecoxib. Annals of the Rheumatic Diseases. 2015 Feb 13 [cited 2017 October 1] http://ard.bmj.com/content/ early/2015/02/13/annrheumdis-2014-206792.info.


[26] Diehl HW, May EL. Cetyl myristoleate isolated from Swiss albino mice: An apparent protective agent against adjuvant arthritis in rat. Journal of Pharmaceutical Science. 1994; 83: 296–299.


[27] Siemandi H et al. Arthritic episodes in patients with various auto-immune diseases characterized by the common terminology “arthritis” and “psoriasis”: A randomized clinical trial. Townsend Letter. Second quarter; 1997.

[28] Whitehouse MW, Macrides TA, Kalafatis N, Betts WH, Haynes DR, Broadbent J. Anti-inflammatory activity of a lipid fraction (Lyprinol) from the NZ green-lipped mussel. Inflammopharmacology. 1997; 5: 237–246.


[29] Lau CS, Chiu PKY, Chu EMY, Cheng IYW, Tang WM, Man RYK, Halpern GM. Treatment of knee osteoarthritis with Lyprinol®, lipid extract of the green-lipped mussel—a double-blind, placebo-controlled study. Progress in Nutrition. 2004; 6(1): 17–31.


[30] Caruso I, Pietrogrande V. Italian double-blind multicenter study comparing S-adenosyl methionine, naproxen and placebo in the treatment of degenerative joint disease. American Journal of Medicine. 1987; 83(5A): 66–71.


[31] Muller-Fassbender H. Double-blind clinical trial of S-adenosyl methionine versus ibuprofen in the treatment of osteoarthritis. American Journal of Medicine. 1987; 83(5A): 81–83.


[32] Soeken KL, Lee WL, Bausell RB, Agelli M, Berman BM. Safety and efficacy of S-adenosyl methionine (SAMe) for osteoarthritis. Journal of Family Practice. 2002; 51(5): 425–430.


[33] Maroon J, Bost J, Baughman J. Results of omega-3 EFA for spine pain. Presented at the American Association Neurological Surgeons Annual Meeting, New Orleans, April 18, 2005.


[34] Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. New England Journal of Medicine. 1985; 312(19): 1210–1216.


[35] Appel LJ, Miller ER, Seidler AJ, Whelton PK. Does supplementation of diet with “fish oil” reduce blood pressure? A meta analysis of controlled clinical trials. Archives of Internal Medicine. 1993; 153(12): 1429–1438.


[36] Issa AM, Mojica WA. The efficacy of omega-3 fatty acids on cognitive function in aging and dementia: A systematic review. Dementia and Geriatric Cognitive Disorders. 2006; 21(2): 88–96.

Return to Prolotherapy Nutrition Connection Page